Open AccessReal-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA
Author(s) -
C. Lance Cowey,
Lisa Mahnke,
Janet L. Espirito,
Christoph Helwig,
Dina Oksen,
Murtuza Bharmal
Publication year - 2017
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2017-0187
Subject(s) - medicine , merkel cell carcinoma , oncology , chemotherapy , merkel cell , population , progression free survival , overall survival , carcinoma , surgery , environmental health
This retrospective study of patients in the USA with metastatic Merkel cell carcinoma (mMCC) aimed to assess patient responses to second-line and later (2L+) and first-line (1L) chemotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom